Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,956 total articles

Eldorado Gold: Skouries Is the Upside Option the Street Is Undervaluing

Eldorado Gold: Skouries Is the Upside Option the Street Is Undervaluing

Eldorado Gold (EGO) is a beaten-down, cash-positive gold developer with a newly enlarged portfolio after the Foran deal. If Skouries - the company's Greece development option - advances toward permitted construction, the company could re-rate materially. This trade idea lays out an actionable long with entry, stop and target, a timeline tied to nea…

Broadcom Dip: A Tactical Buyback Into AI Inference Leadership

Broadcom Dip: A Tactical Buyback Into AI Inference Leadership

Broadcom's pullback near $372 is an opportunity to buy a company with dominant custom AI inference share, $32.8B in free cash flow, and a $1.77T market cap. Valuation is rich (roughly 60x EPS), so this is a tactical, size-managed trade: enter now, trim into strength, and use a defined stop to protect against multiple compression.

Why Zymeworks Paid $929M for Theravance — and How to Trade the Deal

Why Zymeworks Paid $929M for Theravance — and How to Trade the Deal

Zymeworks' $17 per-share offer for Theravance values the company at roughly $929M and buys a fast-growing respiratory franchise (YUPELRI) that generated $266.6M in U.S. net sales in 2025. The union makes strategic sense and creates a tradable setup: buy near technical support and the SMA band, treat the $17 offer as a floor while sizing for legal/c…

Nano Labs (NA) - Cheap, Connected and Asymmetric: A Mid‑Swing Long on AI Chips and Infrastructure Access

Nano Labs (NA) - Cheap, Connected and Asymmetric: A Mid‑Swing Long on AI Chips and Infrastructure Access

Nano Labs (NA) trades at a sub-$50M market cap with a P/E of ~1.9 and a tight float. Management has shown conviction via open-market purchases and recent MoUs that extend the company from chip design into AI data center and infrastructure initiatives. This trade idea takes a mid-term swing long aiming to capture re-rating as product rollouts and pa…

WEC Energy: Data Centers Add a New Layer to a Steady Utility Growth Story

WEC Energy: Data Centers Add a New Layer to a Steady Utility Growth Story

WEC Energy combines Midwest regulated cash flows and a multi-decade dividend track record with a fresh growth vector: large data center load and infrastructure partnerships. At $116.76, the stock offers income (roughly 3.1% yield) plus upside if the company successfully monetizes data center demand and executes capital projects without eroding cred…

Ameren: Large-Load Demand and Grid Investment Can Support a Re-rate

Ameren: Large-Load Demand and Grid Investment Can Support a Re-rate

Ameren (AEE) pairs a stable regulated franchise and 13 years of dividend growth with accelerating transmission investments and the potential for large-load demand to lift the rate base. The balance sheet shows heavier leverage and negative free cash flow as capex runs hot, but the market currently prices the stock at a reasonable P/E and EV/EBITDA …

Whitecap Resources: Buy the Reset, Ride the Production Upside

Whitecap Resources: Buy the Reset, Ride the Production Upside

Whitecap Resources looks positioned to generate outsized returns over the next 45 trading days as improving production, disciplined capital allocation and a conservative balance sheet combine with favorable oil-market dynamics. This trade outlines a clear entry, stop and target and explains the fundamental case, catalysts and risks.

Cardinal Infrastructure: 300%+ Run Is Only The Opening Act

Cardinal Infrastructure: 300%+ Run Is Only The Opening Act

Cardinal Infrastructure (CDNL) has rallied roughly 309% since its IPO but still shows fundamental and technical signs that the company can extend gains. With recent regional tuck-in acquisitions, operational promotions, a tight float and rising short interest, the setup favors a long trade targeting continued market share capture in wet utilities a…

Evommune: Use the Dip — Balance Sheet Gives Time for an AD Re-rate

Evommune: Use the Dip — Balance Sheet Gives Time for an AD Re-rate

Evommune (EVMN) is trading near its 52-week low after a steep pullback from a $33 high. The company's cash position, zero debt and a current ratio above 20 provide runway while development progress on its inflammatory programs (including AD) is awaited. For risk-tolerant swing traders, I propose a long trade at $13.36 with a $21 target over ~45 tra…

SIFCO Industries: Profitable Turnaround with Room to Run

SIFCO Industries: Profitable Turnaround with Room to Run

SIFCO Industries swung to profit in fiscal Q3 2025 and is trading near its 52-week high after a dramatic recovery from last year’s low. With an improving margin profile, positive free cash flow and a low debt load, the stock looks priced for further multiple expansion if operational momentum continues. This is a tactical long idea with clearly defi…